# Programa de Epidemiología Clínica de La Misericordia Clínica Internacional (LMCI)

Programa de Epidemiología Clínica de LMCI para médicos internos, residentes y fellows

La importancia en el conocimiento sobre la distribución y frecuencia de las enfermedades en una población es de
gran interés para el medico en formación y profesionales de la salud. De igual manera, el conocimiento en este
campo les permitirá evaluar críticamente artículos científicos y trabajos de investigación publicados en la literatura
biomedica. Combinar los conceptos teóricos con los adecuados análisis estadísticos les permitirá generar, evaluar e
interpretar la evidencia científica, así como ejecutar una practica medica basada en la evidencia.

### Felipe Guillen-Burgos, MD,MSc

Medico y Cirujano (Pontificia Universidad Javeriana)

Especialista en Ciencia de Datos (Johns Hopkins University, Bloomberg School of Public Health)

Magister en Epidemiologia (Universidad de Los Andes)

Fellow en Neurociencia (Stewart and Lynda Resnick Neuropsychiatric Hospital at University of California)

Director de Investigaciones de LMCI

Director Centro de Investigaciones Clínicas y Traslacional CICT

Investigador Asociado al Departamento de Neurociencias y Departamento de Salud Mental LMCI

Profesor Asociado Universidad Simon Bolivar

Email: investigaciones@lmci.com.co

**Sesiones:**

Día: Miércoles

Hora: 7:00AM

Periodicidad: cada 15 días

Numero de sesiones virtuales: 9

Presencialidad: OBLIGATORIO

**Programa del curso (por favor descargar):** [Programa de Epidemiologia_Internos_LMCI.pdf](https://github.com/felipeguillen/Programa-Epidemiolog-a-Cl-nica-LMCI/files/9055651/Programa.de.Epidemiologia_Internos_LMCI.pdf)

**Seminario 1:**

Fletcher, G. S. (2019). Clinical epidemiology: the essentials. Lippincott Williams & Wilkins. Chapter 1: Introduction.
Pages 2-12:[Clinical Epidemiology_ The Essentials ( PDFDrive ).pdf](https://github.com/felipeguillen/Programa-Epidemiolog-a-Cl-nica-LMCI/files/9055683/Clinical.Epidemiology_.The.Essentials.PDFDrive.pdf)

Nature Communications. (2018). Epidemiology is a science of high importance. Nat Commun, 9(1), 1703: [epidemiology_science_high_importance.pdf](https://github.com/felipeguillen/Programa-Epidemiolog-a-Cl-nica-LMCI/files/9055689/epidemiology_science_high_importance.pdf)

Cimmino, M. A., & Hazes, J. M. (2002). Introduction: value of epidemiological research for clinical practice. Best
Practice & Research Clinical Rheumatology, 16(5), vii-xii.: [cimmino2002.pdf](https://github.com/felipeguillen/Programa-Epidemiolog-a-Cl-nica-LMCI/files/9055694/cimmino2002.pdf)

Pearce, N. (1996). Traditional epidemiology, modern epidemiology, and public health. American journal of public
health, 86(5), 678-683.: [Traditional Epidemiology, Modern Epidemiology, and Public Health.pdf](https://github.com/felipeguillen/Programa-Epidemiolog-a-Cl-nica-LMCI/files/9055696/Traditional.Epidemiology.Modern.Epidemiology.and.Public.Health.pdf)

**Seminario 2:** 

Fletcher, G. S. (2019). Clinical epidemiology: the essentials. Lippincott Williams & Wilkins. Chapter 2: Frequency.
Pages 18-28

Hernández-Avila, M., Garrido-Latorre, F., & López-Moreno, S. (2000). Diseño de estudios epidemiológicos. salud
pública de méxico, 42, 144-154: [Diseños de estudios epidemiologicos.pdf](https://github.com/felipeguillen/Programa-Epidemiolog-a-Cl-nica-LMCI/files/9055701/Disenos.de.estudios.epidemiologicos.pdf)

Grimes, D. A., & Schulz, K. F. (2002). An overview of clinical research: the lay of the land. The lancet, 359(9300),
57-61.: [Grimes2002_An Overview of Clinical Research.pdf](https://github.com/felipeguillen/Programa-Epidemiolog-a-Cl-nica-LMCI/files/9055703/Grimes2002_An.Overview.of.Clinical.Research.pdf)

**Seminario 3:**

Kliewer, M. A. (2006). Writing it up: a step-by-step guide to publication for beginning investigators. Journal of
nuclear medicine technology, 34(1), 53-59: [Writing it up- a step-by-step guide to publication for beginning investigators.pdf](https://github.com/felipeguillen/Programa-Epidemiolog-a-Cl-nica-LMCI/files/9055706/Writing.it.up-.a.step-by-step.guide.to.publication.for.beginning.investigators.pdf)

Cohen, H. (2006). How to write a patient case report. American Journal of Health-System Pharmacy, 63(19),
1888-1892.: [cohen2006_how to write a patient case report.pdf](https://github.com/felipeguillen/Programa-Epidemiolog-a-Cl-nica-LMCI/files/9055708/cohen2006_how.to.write.a.patient.case.report.pdf)

Pautasso, M. (2013). Ten simple rules for writing a literature review. PLoS computational biology, 9(7), e1003149: [Pautasso_Ten Simple Rules for Writing a Literature Review.pdf](https://github.com/felipeguillen/Programa-Epidemiolog-a-Cl-nica-LMCI/files/9055711/Pautasso_Ten.Simple.Rules.for.Writing.a.Literature.Review.pdf)

**Seminario 4:** 

https://pubmed.ncbi.nlm.nih.gov/help/#pubmedhelp.PubMed_Quick_Start

https://www.cebm.ox.ac.uk/resources/ebm-tools/critical-appraisal-tools

https://www.hopkinsmedicine.org/gim/training-education/training/Osler/osler_JAMA_Steps.html

**Seminario 5:** 

Hulley, S. B. (Ed.). (2007). Designing clinical research. Lippincott Williams & Wilkins. Chapter 10. Designing a
Randomized Blinded Trial

Hulley, S. B. (Ed.). (2007). Designing clinical research. Lippincott Williams & Wilkins. Chapter 11. Alternative
Clinical Trial Designs and Implementation Issues: [Designingclinicalresearch4thed.pdf](https://github.com/felipeguillen/Programa-Epidemiolog-a-Cl-nica-LMCI/files/9055726/Designingclinicalresearch4thed.pdf)

Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., ... & Nutt, D. J. (2021).
Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine, 384(15), 1402-1411: [Trial of Psilocybin versus Escitalopram for Depression _ Enhanced Reader.pdf](https://github.com/felipeguillen/Programa-Epidemiolog-a-Cl-nica-LMCI/files/9055734/Trial.of.Psilocybin.versus.Escitalopram.for.Depression._.Enhanced.Reader.pdf)

**Seminario 6:** 

Hulley, S. B. (Ed.). (2007). Designing clinical research. Lippincott Williams & Wilkins. Chapter 7. Designing Cross-
Sectional and Cohort Studies

Hulley, S. B. (Ed.). (2007). Designing clinical research. Lippincott Williams & Wilkins. Chapter 8. Designing Case-
Control Studies

Wang, M. T., Liou, J. T., Lin, C. W., Tsai, C. L., Wang, Y. H., Hsu, Y. J., & Lai, J. H. (2018). Association of
cardiovascular risk with inhaled long-acting bronchodilators in patients with chronic obstructive pulmonary disease:
a nested case-control study. JAMA internal medicine, 178(2), 229-238.: [jamainternal_wang_2018_oi_170120.pdf](https://github.com/felipeguillen/Programa-Epidemiolog-a-Cl-nica-LMCI/files/9055750/jamainternal_wang_2018_oi_170120.pdf)

**Seminario 7:** 

Gordis, L. (2013). Epidemiology E-Book. Elsevier Health Sciences. Chapter 7. Observational Studies. Pages
149-157: [Gordis Epidemiology ( PDFDrive ).pdf](https://github.com/felipeguillen/Programa-Epidemiolog-a-Cl-nica-LMCI/files/9055777/Gordis.Epidemiology.PDFDrive.pdf)

Falaschetti, E., Mindell, J., Knott, C., & Poulter, N. (2014). Hypertension management in England: a serial crosssectional
study from 1994 to 2011. The Lancet, 383(9932), 1912-1919: [Hypertension management in England- a serial cross-sectional study from 1994 to 2011.pdf](https://github.com/felipeguillen/Programa-Epidemiolog-a-Cl-nica-LMCI/files/9055781/Hypertension.management.in.England-.a.serial.cross-sectional.study.from.1994.to.2011.pdf)

Mackenzie, N., Lopez-Coronel, E., Dau, A., Maloof, D., Mattar, S., Garcia, J. T., ... & Guillen-Burgos, H. F. (2021).
Concomitant Guillain-Barre syndrome with COVID-19: a case report. BMC neurology, 21(1), 1-4.: [Concomitant Guillain-Barre syndrome with COVID-19- a case report.pdf](https://github.com/felipeguillen/Programa-Epidemiolog-a-Cl-nica-LMCI/files/9055785/Concomitant.Guillain-Barre.syndrome.with.COVID-19-.a.case.report.pdf)

**Seminario 8:** 

Murad, M. H., Jaeschke, R., Devereaux, P. J., Prasad, K., Carrasco-Labra, A., Agoritsas, T., ... & Guyatt, G. (2015).
The process of a systematic review and meta-analysis. Users’ guides to the medical literature: a manual for
evidenced-based clinical practice, 3, 459-469: [The_Process_of_a_Systematic_Review_and_Meta-analysis-Guides-to-the-Medical-Literature.pdf](https://github.com/felipeguillen/Programa-Epidemiolog-a-Cl-nica-LMCI/files/9055791/The_Process_of_a_Systematic_Review_and_Meta-analysis-Guides-to-the-Medical-Literature.pdf)

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., ... & Moher, D. (2021).
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Systematic reviews, 10(1),
1-11: [page2021_PRISMA_statement.pdf](https://github.com/felipeguillen/Programa-Epidemiolog-a-Cl-nica-LMCI/files/9055797/page2021_PRISMA_statement.pdf)

Wu, T., Jia, X., Shi, H., Niu, J., Yin, X., Xie, J., & Wang, X. (2021). Prevalence of mental health problems during the
COVID-19 pandemic: A systematic review and meta-analysis. Journal of affective disorders, 281, 91-98.: [Wu2021_Mentalhealth_COVID19_metaanalysis.pdf](https://github.com/felipeguillen/Programa-Epidemiolog-a-Cl-nica-LMCI/files/9055799/Wu2021_Mentalhealth_COVID19_metaanalysis.pdf)



